TriSalus Life Sciences Stock Price, News & Analysis
Company Description
TriSalus Life Sciences (NASDAQ: TLSIW) is a publicly traded company in the Surgical & Medical Instruments & Apparatus sector.
TLSIW stock has declined 54.7% over the past year. Shares last traded at $0.5800.
On a trailing twelve-month basis, TriSalus Life Sciences reported revenue of $45.2M with net income of -$39.2M and diluted earnings per share of $-1.84. The company operates at a net profit margin of -86.9%.
This page provides a comprehensive overview of TLSIW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
TriSalus Life Sciences (TLSIW) stock last traded at $0.5800, down 14.79% from the previous close. Over the past 12 months, the stock has lost 54.7%.
TLSIW Rankings
Latest News
SEC Filings
TriSalus Life Sciences has filed 10 recent SEC filings, including 10 Form 4. The most recent filing was submitted on May 19, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TLSIW SEC filings →
Financial Highlights
TriSalus Life Sciences generated $45.2M in revenue over the trailing twelve months, retaining a 84.6% gross margin, operating income reached -$26.9M (-59.7% operating margin), and net income was -$39.2M, reflecting a -86.9% net profit margin. Diluted earnings per share stood at $-1.84. The company generated -$18.0M in operating cash flow. With a current ratio of 2.80, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in TriSalus Life Sciences (TLSIW) currently stands at 5.0 thousand shares, up 24.1% from the previous reporting period. Over the past 12 months, short interest has increased by 552.9%. The 7.3 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for TriSalus Life Sciences (TLSIW) currently stands at 7.3 days, up 165.1% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 629% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 9.1 days.
TLSIW Company Profile & Sector Positioning
TriSalus Life Sciences (TLSIW) operates in the Surgical & Medical Instruments & Apparatus sector and is listed on the NASDAQ.